In:
Open Forum Infectious Diseases, Oxford University Press (OUP), Vol. 2, No. 1 ( 2015-01-01)
Abstract:
Background. In the United States, measles, mumps, rubella, and varicella immunity is now primarily achieved through vaccination. Monitoring population immunity is necessary. Methods. We evaluated seroprevalence of antibodies to measles, mumps, rubella, and varicella using the National Health and Nutrition Examination Survey during 2009–2010. Results. Measles, mumps, rubella, and varicella seroprevalence was 92.0% (95% confidence interval [CI], 90.9%−93.0%), 87.6% (CI, 85.8%−89.2%), 95.3% (CI, 94.3%−96.2%), and 97.8% (CI, 97.1%−98.3%), respectively. United States (US)-born persons had lower mumps seroprevalence and higher varicella seroprevalence than non-US born persons. Conclusions. Seroprevalence was high (88%–98%) for all 4 viruses in the US population during 2009−2010.
Type of Medium:
Online Resource
ISSN:
2328-8957
Language:
English
Publisher:
Oxford University Press (OUP)
Publication Date:
2015
detail.hit.zdb_id:
2757767-3
Permalink